With Wuhan virus genetic code in hand, scientists begin work on a vaccine


  • World
  • Saturday, 25 Jan 2020

FILE PHOTO: A traveler wearing a mask arrives on a direct flight from China, after a spokesman from the U.S. Centers for Disease Control and Prevention (CDC) said a traveler from China had been the first person in the United States to be diagnosed with the Wuhan coronavirus, at Seattle-Tacoma International Airport in Washington, U.S. January 23, 2020. REUTERS/David Ryder

CHICAGO/LONDON (Reuters) - When a newly organised vaccine research group at the U.S. National Institutes of Health (NIH) met for the first time this week, its members had expected to be able to ease into their work. But their mandate is to conduct human trials for emerging health threats - and their first assignment came at shocking speed.

In just three months time, they likely will be testing the first of a number of potential experimental vaccines against the new SARS-like coronavirus that is spreading in China and beyond.

Get 30% off with our ads free Premium Plan

Monthly Plan

RM9.73/month

Annual Plan

RM8.63/month

Billed as RM103.60/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Why you shouldn’t put your smartphone in rice after dropping it in water
Russia says G20 Ukraine discussion is 'destructive'
UN sanctions six Congo rebels as fighting in east escalates
US believes Russia developing space-based nuclear weapon, says source
Researchers identify 275 mln new genetic variants: study
Roundup: Powerful storm soaks U.S. California as nearly entire population under flood alerts
New Zealand parliamentarian dies during charity race
Person killed in shooting in U.S. Santa Clara, suspect arrested
U.S. stocks end lower as tech giants drag heels
Stellantis plans to produce Chinese EV in Italy

Others Also Read